8-K/A
Current Report
Protalix BioTherapeutics, Inc. Filed Acc 0001558370-20-011697
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading plx-20200607x8ka.htm…